Available On-Demand Through January 14, 2024!
The live event was held on October 27, 2023, but you can still register for the on-demand content through January 14, 2024.
Chair: Colleen Le Prell, PhDCo-Chair: Gayla Poling, PhD
The fields of audiology and hearing science are vastly advancing. Nearly a quarter of Americans older than 12 years of age are estimated to have some degree of hearing loss. As most older adults will experience hearing loss, inner-ear regeneration and cell therapies would significantly expand remediation options beyond amplification devices alone.
Research indicates that inner-ear protective and regenerative therapies are promising and could lead to significant changes in audiological management. Multiple therapeutics are currently under evaluation in animal models and human clinical trials, with the potential for new medicines thus on the horizon.
This virtual conference aims to describe the current state of these therapies and provide future expectations for clinicians providing hearing-related services.
Agenda
| 8:00–8:15 am | Welcome–Background and Introductory Session Bopanna Ballachanda, PhD, Academy President Colleen Le Prell, PhD, ARC 2023 Program Chair |
| 8:15–9:00 am | Developing and Testing Therapies for the Inner Ear Colleen Le Prell, PhD, University of Texas at Dallas |
| 9:00–9:45 am | Cisplatin Ototoxicity and Its Prevention Lisa Cunningham, PhD, National Institute on Deafness and Other Communication Disorders (NIDCD) |
| 9:45–10:00 am | Break |
| 10:00–10:45 am | Gene Therapies for Childhood Hearing Loss Karen Avraham, PhD, Tel Aviv University |
| 10:45–11:30 am | Panel Discussion/Questions |
| 11:30 am–12:00 pm | Selected Industry Presentations |
| 12:00–1:00 pm | Lunch Break |
| 1:00–1:15 pm | Welcome – Advanced Session Gayla Poling PhD, ARC 2023 Program Committee Co-Chair |
| 1:15–2:00 pm | Noise-Induced Hearing Loss and its Prevention COL Samuel Spear MC USAF. Chief, DOD Hearing Center of Excellence, Defense Health Agency. Joint Base San Antonio, TX LTC Isaac Erbele MC USA. Chief of Neurotology, Associate Program Director, Brooke Army Medical Center, Joint Base San Antonio, TX |
| 2:00–2:45 pm | Aminoglycoside Ototoxicity and its Prevention Angela Garinis, PhD, National Center for Rehabilitative Auditory Research (NCRAR) |
| 2:45–3:00 pm | Break |
| 3:00–3:45 pm | Beyond the Audiogram: Lessons from Clinical Trials Victoria Sanchez, AuD, PhD, University of South Florida |
| 3:45–4:30 pm | The Audiologist in the Next Generation of Inner-Ear Therapies: From Devices to Drugs Angela Shoup, PhD, Callier Center for Communication Disorders/University of Texas-Dallas |
| 4:30–5:15 pm | Panel Discussion/Questions |
| 5:15–5:30 pm | Closing Remarks Colleen Le Prell, PhD, ARC 2023 Program Committee Chair |
Available On-Demand Through January 14, 2024!
The live event was held on October 27, 2023, but you can still register for the on-demand content through January 14, 2024.
Chair: Colleen Le Prell, PhDCo-Chair: Gayla Poling, PhD
The fields of audiology and hearing science are vastly advancing. Nearly a quarter of Americans older than 12 years of age are estimated to have some degree of hearing loss. As most older adults will experience hearing loss, inner-ear regeneration and cell therapies would significantly expand remediation options beyond amplification devices alone.
Research indicates that inner-ear protective and regenerative therapies are promising and could lead to significant changes in audiological management. Multiple therapeutics are currently under evaluation in animal models and human clinical trials, with the potential for new medicines thus on the horizon.
This virtual conference aims to describe the current state of these therapies and provide future expectations for clinicians providing hearing-related services.
Agenda
| 8:00–8:15 am | Welcome–Background and Introductory Session Bopanna Ballachanda, PhD, Academy President Colleen Le Prell, PhD, ARC 2023 Program Chair |
| 8:15–9:00 am | Developing and Testing Therapies for the Inner Ear Colleen Le Prell, PhD, University of Texas at Dallas |
| 9:00–9:45 am | Cisplatin Ototoxicity and Its Prevention Lisa Cunningham, PhD, National Institute on Deafness and Other Communication Disorders (NIDCD) |
| 9:45–10:00 am | Break |
| 10:00–10:45 am | Gene Therapies for Childhood Hearing Loss Karen Avraham, PhD, Tel Aviv University |
| 10:45–11:30 am | Panel Discussion/Questions |
| 11:30 am–12:00 pm | Selected Industry Presentations |
| 12:00–1:00 pm | Lunch Break |
| 1:00–1:15 pm | Welcome – Advanced Session Gayla Poling PhD, ARC 2023 Program Committee Co-Chair |
| 1:15–2:00 pm | Noise-Induced Hearing Loss and its Prevention COL Samuel Spear MC USAF. Chief, DOD Hearing Center of Excellence, Defense Health Agency. Joint Base San Antonio, TX LTC Isaac Erbele MC USA. Chief of Neurotology, Associate Program Director, Brooke Army Medical Center, Joint Base San Antonio, TX |
| 2:00–2:45 pm | Aminoglycoside Ototoxicity and its Prevention Angela Garinis, PhD, National Center for Rehabilitative Auditory Research (NCRAR) |
| 2:45–3:00 pm | Break |
| 3:00–3:45 pm | Beyond the Audiogram: Lessons from Clinical Trials Victoria Sanchez, AuD, PhD, University of South Florida |
| 3:45–4:30 pm | The Audiologist in the Next Generation of Inner-Ear Therapies: From Devices to Drugs Angela Shoup, PhD, Callier Center for Communication Disorders/University of Texas-Dallas |
| 4:30–5:15 pm | Panel Discussion/Questions |
| 5:15–5:30 pm | Closing Remarks Colleen Le Prell, PhD, ARC 2023 Program Committee Chair |
More Events
Unveiling the Truth About Cochlear Implants
Presenter: Meredith Holcomb, AuD CEUs: 0.1 AAA / Tier 1 CEUs Duration: 60 minutes Instructional Level: Intermediate Program Focus: Knowledge Description: The utilization rate for cochlear…
Read More
